Endpoints for Validation of Tumour Markers for Recurrence Risk - Recurrence-free Interval (RFI), Disease-free Survival (DFS), Overall Survival (OS), and Colon-cancer Specific Survival (CCSS) in CALGB 9581

被引：0
|
作者：
Mahmoud, N. N. [1 ]
Lopatin, M. [2 ]
Clark-Langone, K. [2 ]
Lee, M. [2 ]
Niedzwiecki, D. [3 ]
Venook, A. P. [4 ]
机构：
[1] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA
[2] Genom Hlth Inc, Med Oncol, Redwood City, CA USA
[3] Duke Univ, Durham, NC USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)70904-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S172 / S172
页数：1
相关论文
共 50 条
  • [21] The tumor distance to the main hepatic vessels is a predictor of recurrence-free survival and overall survival in hepatocellular cancer
    Abdelhadi, Schaima
    Rink, Johann S.
    Froelich, Matthias F.
    Sandra-Petrescu, Flavius
    El-Ahmar, Mohamad
    Oweira, Hani
    Rahbari, Nuh N.
    Reissfelder, Christoph
    Birgin, Emrullah
    LANGENBECKS ARCHIVES OF SURGERY, 2025, 410 (01)
  • [22] Effect of metformin on recurrence-free survival and overall survival in diabetic patients affected by advanced ovarian cancer
    Simonelli, Cecilia
    Bertolotti, Monica
    Sabbatini, Paul
    Berek, Jonathan S.
    Pfisterer, Jacobus
    Binaschi, Monica
    Otranto, Isabella
    Maggi, Carlo Alberto
    Scartoni, Simona
    Capriati, Angela
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] Disease-free survival (DFS) and distant metastasis-free survival (DMFS) as surrogates for overall survival (OS) in adjuvant treatment of muscle-invasive bladder cancer (MIBC)
    Sternberg, C.
    Squifflet, P.
    Burdett, S.
    Fisher, D.
    Saad, E. D.
    Kurt, M.
    Teitsson, S.
    May, J. R.
    Stoeckle, M.
    Torti, F.
    Cote, R.
    Groshen, S.
    Ruggeri, E.
    Zhegalik, A.
    Tierney, J.
    Collette, L.
    Burzykowski, T.
    Buyse, M. E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1335 - S1336
  • [24] A novel epigenetic signature to predict recurrence-free survival in patients with colon cancer
    Dai, Qi-xin
    Liao, Yong-hui
    Deng, Xiao-hong
    Xiao, Xiu-lin
    Zhang, Long
    Zhou, Lin
    CLINICA CHIMICA ACTA, 2020, 508 : 54 - 60
  • [25] Correlations between disease-free survival (DFS) and overall survival (OS) in patients (pts) with renal cell carcinoma (RCC) at high risk for recurrence: Results from S-TRAC trial
    George, D. J.
    Pantuck, A. J.
    Figlin, R.
    Escudier, B.
    Halabi, S.
    Casey, M.
    Lin, X.
    Serfass, L.
    Frean, M. J. Lechuga
    Ravaud, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 312 - 312
  • [26] A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival
    Tian-bao Huang
    Chuan-peng Dong
    Guang-chen Zhou
    Sheng-ming Lu
    Yang Luan
    Xiao Gu
    Lei Liu
    Xue-fei Ding
    International Urology and Nephrology, 2017, 49 : 825 - 835
  • [27] A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival
    Huang, Tian-bao
    Dong, Chuan-peng
    Zhou, Guang-chen
    Lu, Sheng-ming
    Luan, Yang
    Gu, Xiao
    Liu, Lei
    Ding, Xue-fei
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (05) : 825 - 835
  • [28] Survival after Locoregional Recurrence or Second Primary Breast Cancer: Impact of the Disease-Free Interval
    Witteveen, Annemieke
    Kwast, Annemiek B. G.
    Sonke, Gabe S.
    IJzerman, Maarten J.
    Siesling, Sabine
    PLOS ONE, 2015, 10 (04):
  • [29] SURVIVAL AFTER LOCOREGIONAL RECURRENCE OR SECOND PRIMARY BREAST CANCER: IMPACT OF THE DISEASE-FREE INTERVAL
    Witteveen, A.
    Kwast, A. B. G.
    Sonke, G.
    IJzerman, M. J.
    Siesling, S.
    VALUE IN HEALTH, 2014, 17 (07) : A620 - A620
  • [30] RAS Mutations Predict Recurrence-Free Survival and Recurrence Patterns in Colon Cancer: A Unicenter Study in Morocco
    El Agy, Fatima
    El Bardai, Sanae
    Boukansa, Sara
    Bouguenouch, Laila
    Benbrahim, Zineb
    Mazaz, Khalid
    Benjelloun, El Bachir
    Ousadden, Abdelmalek
    Ouldim, Karim
    Ibrahimi, Sidi Adil
    Chbani, Laila
    CANCER CONTROL, 2024, 31
12345